![]() |
|
|
Vol. 285, Issue 1, 342-349, April 1998
Institut National de la Santé et de la Recherche Médicale (INSERM U 317), Institut Louis Bugnard, Université Paul SABATIER, C.H.U. Rangueil, 31403 Toulouse Cedex 4, France (L.M., N.M., D.P., M.L., C.C.); and Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 645, 08028 Barcelona, Spain (G.E.T., X.T., A.Z.)
| |
Abstract |
|---|
|
|
|---|
Nonadrenergic imidazoline I2-binding sites colocalize with monoamine oxidase (MAO) in various tissues. As white adipocytes from various species have been reported to be very rich in I2-sites, the authors consider whether these cells show a substantial MAO activity and explore its functional role. Oxidation of [14C]tyramine by rat adipocyte membranes was dependent on both MAO and semicarbazide-sensitive amine oxidase (SSAO). Tyramine oxidation was identical in membranes and in intact adipocytes (Vmax: 11-12 nmol/min/mg protein). A similar effect of MAO and SSAO inhibitors was obtained in both the intact cells and the membranes: half of the activity was sensitive to semicarbazide and the other half more easily inhibited by MAO-A than by MAO-B inhibitors. As the reaction catalyzed by amine oxidases generates H2O2, which mimicks certain insulin effects in adipocytes, we tested whether tyramine oxidation influences glucose transport in adipocytes. One mM tyramine weakly stimulated glucose transport. A clear potentiation of tyramine effect occurred in the presence of 0.1 mM vanadate, ineffective by itself, reaching half-maximal insulin stimulation. This stimulation was sensitive to MAO and SSAO inhibitors and to catalase. The 5-fold activation of glucose transport was accompanied by translocation of GLUT4 transporters to the plasma membrane. This shows that tyramine is readily oxidized by adipocytes and potentiates the effects of vanadium on glucose transport through release of hydrogen peroxide. The role of the amine oxidases, which are highly expressed in adipocytes, allows them to be considered as more than mere scavengers of circulating amines.
| |
Introduction |
|---|
|
|
|---|
Among
the various peripheral tissues, adipose tissue has been shown to be one
of the richest in imidazoline binding sites (for review see Parini
et al., 1996
). These binding sites are now pharmacologically
classified as I1- and
I2-sites (Ernsberger, 1992
). They are
characterized by their high affinity for imidazolinic ligands
(clonidine for I1 and idazoxan for
I2) but their biological function remains to be
defined. Imidazoline-I2 binding sites, which are
labeled by [3H]idazoxan, are particularly
abundant in white adipocytes, at least in rats (Carpéné
et al., 1990
; 1995b
), hamsters (McKinnon et al.,
1989
; Carpéné et al., 1995b
) and humans (Langin
et al., 1990
). The imidazoline-I2
sites have recently been localized on MAO (EC 1.4.3.4) by several
observations (reviewed in Parini et al., 1996
). This
I2-site/MAO association, together with the abundance of I2-sites in the fat cell, prompted
us to reassess the monoamine oxidizing capacity of white adipocytes in
which the presence and role of MAO is poorly documented. In fact,
oxidation of monoamines or neurotransmitters has been more widely
described in brown than in white adipocytes (Barrand and Callingham,
1982
). Pioneering studies on the oxidation of tyramine and benzylamine by adipocyte preparations revealed the presence of another amine oxidase, resistant to blockade by the classical inhibitors of MAO-A and
MAO-B, but inhibited by carbonyl reagents such as semicarbazide. It was
thus called SSAO (EC 1.4.3.6) in both brown (Barrand and Callingham,
1982
) and white adipocytes (Raimondi et al., 1991
, 1992
). In
our study, we describe the relative proportions of each of the adipose
amine oxidases in tyramine oxidation. Their functional relevance was
investigated by comparing their activities on crude membrane
preparations (containing plasma, mitochondrial and vesicular membranes)
and in intact fat cells. It is hypothesized that amine oxidases are not
only scavengers for circulating endogenous and exogenous amines, but
could also be involved in the regulation of glucose metabolism via the
hydrogen peroxide they all produce. In fact, hydrogen peroxide is
considered as an insulinomimetic agent by several investigators
(Heffetz et al., 1992
; Taylor and Halperin, 1979
) but also
as a second messenger in insulin signaling by others (May and De Ha
137 n, 1979
; Mukherjee, 1980
). Recently, we demonstrated in
cardiomyocytes that serotonin-stimulated glucose uptake is mediated by
the MAO-dependent degradation of the bioamine and the subsequent
hydrogen peroxide formation (Fischer et al., 1995
). A
similar approach has also shown that phenylephrine, a potent stimulator
of cardiomyocyte glucose transport, exerts a biphasic effect: a fast
receptor-mediated phase and a slow MAO-dependent phase (Fischer
et al., 1996
). Moreover, hydrogen peroxide is also able to
oxidize vanadyl into vanadate (Elberg et al., 1994
) and to
transform vanadate into peroxovanadate, a most powerful
insulin-mimicking agent (Shisheva and Shechter, 1993
). In our study,
the hydrogen peroxide generated by amine oxidases, was thus tested for
its ability to activate glucose transport in white adipocytes, alone or
in synergism with vanadate.
Even though the effects of MAO inhibitors have only been poorly studied in adipocytes, our results indicate that the oxidation of tyramine is far from negligible in these cells. The study also shows that tyramine and vanadate synergistically stimulate glucose transport via activation of SSAO and MAO-A; MAO-B being involved to a lesser extent. Thus, the highly active peroxovanadate can be generated not only by exogenous hydrogen peroxide, but also by the hydrogen peroxide endogenously produced by fat cells during amine oxidation.
| |
Materials and Methods |
|---|
|
|
|---|
Adipocyte isolation and crude membrane preparation.
Male
Wistar rats (200-260 g) were killed in a fed state, and the internal
white adipose tissues (perirenal, epididymal and retroperitoneal fat
depots) were dissected out and digested in Krebs-Ringer buffer
containing albumin (3.5% w/v), 15 mM sodium bicarbonate, 10 mM Hepes,
2 mM sodium pyruvate and 1.5 mg/ml collagenase. After digestion for 35 to 45 min at 37°C under shaking, isolated fat cells were filtered and
washed three times in the same buffer without collagenase (KRBH
buffer). Freshly isolated adipocytes were adjusted to a suitable
dilution (around 30 mg cell lipid/ml of KRBH) and dispensed in plastic
vials (final volume 400 µl) for parallel determinations of amine
oxidase and glucose transport activities. In other sets of experiments,
isolated fat cells were disrupted for crude membrane preparation by
hypo-osmotic lysis and centrifugation (40,000 × g, 20 min, 15-20°C) in a 2 mM Tris buffer containing 2.5 mM
MgCl2, 1 mM KHCO3 and an
antiprotease cocktail as previously described (Carpéné
et al., 1990
). The pellets were immediately stored at
-80°C until amine oxidase assay.
Determination of amine oxidase activity.
Amine oxidase
activity was measured according to the method of Yu (1986)
using
[14C]tyramine as a substrate. For the
measurement of tyramine oxidation by crude membranes, thawed pellets
were washed in 200 mM phosphate buffer, pH 7.4 and repelleted by
centrifugation (40,000 × g, 15 min, 4°C). Then,
unless otherwise stated, approximately 50 µg of membrane proteins
were incubated for 30 min at 37°C in 200 µl phosphate buffer
containing 0.5 mM tyramine (approx. 120,000 d.p.m./vial). Tyramine
oxidation by intact adipocytes was carried out in KRBH buffer with an
incubation period of 45 min at 37°C in the presence of 1 mM tyramine
(130,000 d.p.m./vial) except for the kinetic experiments. For the
determinations of Km and Vmax values, membrane and adipocyte
preparations were incubated with 44 ± 16 and 40 ± 3 µg
membrane protein/vial for 15 and 30 min, respectively, with six
different tyramine concentrations, ranging from 40 µM to 1 mM.
Reactions were stopped with 50 µl of 4 M HCl. The reaction products
were extracted by subsequent addition of 1 ml of solvent (toluene:ethyl
acetate, v/v). An aliquot (0.7 ml) of the organic phase was transferred
into scintillation vials and counted in a Packard 1900TR liquid
scintillation analyzer (Rungis, France). In these conditions, product
formation proceeded linearly and the initial rate was a linear function
of enzyme concentration. Kinetic constants were estimated from double
reciprocal plots. In both membrane and intact cell preparations,
oxidation activities were expressed in nanomoles of tyramine oxidized
per min and per mg of membrane proteins. For the whole cells, the protein content was determined on the pellet obtained after
centrifugation (40,000 × g, 15 min) of 5 ml of the
same cell suspension as that used with
[14C]tyramine in the conditions described
above. The proportion of membrane proteins (in mg) per 100 mg of
cellular lipid was around 0.24.
Hexose transport.
After a preincubation period of 45 min at
37°C in vials containing 400 µl of cell suspension in KRBH with the
tested drugs, [3H]-2-deoxyglucose was added at
a final concentration of 0.1 mM (approx. 1,300,000 d.p.m./vial). The
assays were further incubated for 5 or 10 min and then stopped with 100 µl of 100 µM cytochalasin B. Aliquots (200 µl) of the cell
suspension were centrifuged in microtubes as described by Olefsky
(1978)
. After centrifugation, the fat cells (upper part of the tubes)
were placed in scintillation vials and the incorporated radioactivity
was counted. The extracellular 2-DG present in the cell fraction was
determined using adipocytes whose transport activity had been
previously blocked by cytochalasin B. It did not exceed 1% of the
maximum 2-DG uptake in the presence of insulin.
Subcellular fractionation of adipocytes and immunoblot
analysis.
Fat cell suspensions obtained from a pool of nine rats
were incubated for 45 min in plastic vials containing 20 ml of KRBH buffer and the tested compounds. The cells were then homogenized, and
subcellular membrane fractions were prepared as previously described
(Simpson et al., 1983
). PM and LDM were assayed for protein
content and aliquots were subjected to SDS-PAGE and transferred to
Immobilon-P membranes as already reported (Camps et al.,
1992
). Briefly, membrane proteins were transferred to Immobilon in
buffer consisting of 20% methanol, 200 mM glycine, 25 mM Tris, pH 8.3. After transfer, the filters were blocked for 1 hr at 37°C with 5%
nonfat dry milk, 0.02% sodium azide in 137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4 and 1.7 mM
KH2PO4 and were incubated
with antibodies. The immune complex with the rabbit polyclonal
antibodies was detected using [125I]-protein A
for 4 hr at room temperature and autoradiography. The areas at 45 kDa
and 110 kDa corresponding to the GLUT4 and
1-integrin bands,
respectively, were quantified using scanning densitometry (Ultrascan
enhancer laser densitometer, LKB, Les Ulis, France).
Stastical analysis. The number of independent experiments is given by n. Unless otherwise stated, Student's t test for unpaired samples was used for detect the significant difference between the compared results, given as mean ± S.E.M. NS corresponds to non-significant difference (P > .05).
Chemicals.
[14C]tyramine (45 Ci/mmol) and 2-[1,2-3H]-deoxyglucose (2-DG, 26 Ci/mmol) came from NEN (Boston, MA).
[125I]-Protein A was purchased from Amersham
(Les Ulis, France). Selegiline was from RBI (Natick, MA). Sodium
orthovanadate, pargyline, semicarbazide, clorgyline, phenelzine,
collagenase, cytochalasin B, tyramine,
-globulin, albumin (bovine
serum albumin, fraction V) and other chemicals were purchased from
Sigma Chemicals Co. (St. Quentin, France). Immobilon-P membranes were
obtained from Millipore (Saint Quentin en Yvelines, France). All
electrophoresis reagents and molecular weight markers were obtained
from Bio-Rad (Ivry sur Seine, France). Anti-GLUT4 antibodies were
produced from rabbit after immunization with a peptide corresponding to
the final 15 amino acids of the carboxy terminus (Camps et
al., 1992
). Rabbit polyclonal antibodies against rat
1-integrin were kindly given by Dr. C. Enrich
(Barcelona University, Barcelona, Spain).
| |
Results |
|---|
|
|
|---|
Tyramine oxidation by crude membranes and by intact white
adipocytes.
In crude membranes from rat adipocytes, tyramine
oxidation was characterized by a Vmax of
11.9 ± 1.4 nmol tyramine oxidized/min/mg protein
(n = 4), a value similar to that previously reported
for liver membranes (Carpéné et al., 1995a
). The
same Vmax was reached with intact fat
cells: 11.4 ± 1.5 nmol/min/mg membrane protein (n = 4, NS). The Km values were 85 ± 18 and 138 ± 22 µM for crude membranes and isolated adipocytes,
respectively (n = 4, NS). The Km values for tyramine, a common substrate
of MAO-A, MAO-B and SSAO, are in accordance with those found in the
literature (Barrand and Callingham, 1982
; Lyles, 1995
). Thus, the
Michaelis kinetic constants were similar in both disrupted and intact
cells suggesting that tyramine internalization was not a limiting step
for its oxidation. To further characterize the relative importance of the enzymes involved, experiments were carried out with increasing concentrations of amine oxidase inhibitors. The MAO-A inhibitor clorgyline was the most potent inhibitor in both membrane and intact
cell preparations (fig. 1, A and B). In
membranes, the MAO-B inhibitor selegiline shared the same low potency
as pargyline, a less-selective MAO inhibitor (half-maximal inhibitions
being obtained at around 20 µM). Selegiline was the weakest inhibitor when tested on intact cells. Semicarbazide, which selectively blocks
SSAO but not MAO, was able to diminish tyramine oxidation in both
preparations. However, complete inhibition of tyramine oxidation was
obtained neither on membranes nor on fat cells, even with each
inhibitor present at millimolar concentrations. The inhibitor-resistant
oxidation (ca. 50% of total oxidation) was not due to
nonenzymatic tyramine oxidation because blanks, obtained without any
biological material or with denatured samples gave values of less than
5% of total oxidation (not shown). Figure 2 clearly shows that the
inhibitions obtained with 1 mM pargyline and with 1 mM semicarbazide
were additive. When both inhibitors were present in the incubation
medium, they almost totally abolished tyramine oxidation. This was also
observed with clorgyline plus selegiline when mixed with semicarbazide
(not shown). SSAO and MAO equally participated in the tyramine
oxidation by crude membranes or intact cells (fig.
2).
|
|
|
Effect of amine oxidase substrates on glucose transport in isolated
fat cells.
Because some amines behaved as substrates of amine
oxidases in intact adipocytes and because it is known that amine
oxidases produce hydrogen peroxide during the oxidative deamination
reaction (Yu, 1986
), we tested whether amine oxidation could mimick the action of insulin on glucose transport through the generation of
hydrogen peroxide. Indeed, it has been reported that exogenously added
hydrogen peroxide stimulates protein phosphorylation and glucose
transport in rat adipocytes (Heffetz et al., 1992
; Taylor and Halperin, 1979
) but similar responses to endogenously produced H2O2 have never been
reported. Glucose transport was not activated after 45 min
preincubation of fat cells with increasing concentrations of tyramine,
serotonin or phenylephrine whereas, in the same conditions (5-min 2-DG
uptake), insulin increased basal uptake 12-fold (fig. 3). When the period of 2-DG transport was
extended to 10 min, 1 mM tyramine slightly increased basal transport
from 1.0 ± 0.2 to 1.7 ± 0.3 nmol 2-DG/100 mg lipid
(n = 7, P < .01, paired t test) whilst
100 nM insulin stimulated up to 11.6 ± 1.6 nmol 2-DG/100 mg lipid
(n = 7, P < .001). Increasing the preincubation
period from 45 to 120 min did not cause the amines to further stimulate glucose transport except for 0.1 mM tyramine which just increased transport up to 13% of the maximal insulin value (fig. 3). However, exogenously added H2O2
dose-dependently stimulated hexose transport. When preincubation lasted
45 min, 1 mM H2O2
multiplied the basal transport by a 5.0 ± 0.8 fold factor, an
effect equivalent to 46% that of the maximal insulin effect
(n = 23). The response then declined at concentrations
higher than 1 mM (not shown). Thus, in the presence of tyramine, the
H2O2 produced by adipocyte amine oxidases was insufficient or was immediately counteracted by
endogenous scavenger systems and did not reproduce the effects of high
doses of exogenous H2O2.
|
Potentiation by vanadate of tyramine effect on 2-deoxyglucose uptake. Figure 4 shows that vanadate potentiates the effect of tyramine as well as that of hydrogen peroxide. Vanadate alone (0.1 mM) did not affect basal or insulin-stimulated glucose transport, whereas, when combined with 1 mM hydrogen peroxide it provoked a substantial activation equivalent to three quarters of the maximal effect of insulin. Combination of vanadate with 1 mM serotonin or phenylephrine resulted in only weak activation of glucose transport that hardly doubled basal activity and represented 8 ± 2 and 12 ± 2% of maximal insulin effect (n = 5) whereas agmatine was inefficient (not shown). On a larger number of observations (n = 40), the stimulation of glucose transport induced by 1 mM tyramine plus 0.1 mM vanadate reached 54 ± 5% that of 100 nM insulin whilst vanadate alone reached only 5 ± 1% of the maximal insulin effect (vanadate plus insulin giving the same response as insulin alone: 102 ± 3%, n = 40). Moreover, there was no synergism between tyramine and low, ineffective, doses of insulin (10 pM) or hydrogen peroxide (0.01 mM) (not shown).
|
Prevention of vanadate/tyramine synergism by blockade of amine oxidase activity and by hydrogen peroxide degradation. The dose-dependent stimulation of glucose transport by tyramine plus vanadate was inhibited by most of the amine oxidase inhibitors tested, whereas none of them altered basal transport (fig. 5). Selegiline, which selectively inhibits MAO-B (seen to be a minor component of tyramine oxidation in figs. 1 and 2), was the only inhibitor unable to block the tyramine-dependent transport. When present at 0.1 mM, semicarbazide or clorgyline inhibited 59 ± 7 and 42 ± 3% of the transport promoted by 1 mM tyramine plus vanadate, but they inhibited less than 30% when tested at 10 µM (n = 4, not shown). Glucose transport stimulated by 1 mM hydrogen peroxide plus 0.1 mM vanadate was unaffected by 1 mM of the amine oxidase inhibitors tested alone (fig. 5) or in combination (not shown).
|
|
GLUT4 translocation induced by tyramine plus vanadate.
To
verify whether the stimulation of glucose transport in rat adipocytes
may be explained by a translocation of the insulin-sensitive glucose
transporters from an internal site to the plasma membrane, as already
demonstrated for insulin (Simpson et al., 1983
), the amount
of GLUT4 protein was determined in PM and LDM fractions. Western blot
analysis showed that, in conditions where insulin increased the amount
of GLUT4 protein in the PM by 252 ± 43% (n = 3),
tyramine plus vanadate increased it by 163 ± 9% (around half the
insulin effect) whereas vanadate at 0.1 mM alone was inefficient
(103 ± 8%). These increases in GLUT4 content occurred without
any significant change in the content of
1-integrin, a constitutive
PM protein (fig. 7). Changes in the GLUT4
content of LDM mirrored, to a lesser extent, those reported in the PM (basal LDM content was decreased by 29 and 12% with insulin and tyramine plus vanadate respectively, not shown).
|
| |
Discussion |
|---|
|
|
|---|
The relatively high level of amine oxidase activity reported here
for white adipocytes is rather surprising because adipose tissue does
not belong to the classical group of tissues known to participate in
the clearance of endogenous or exogenous amines, essentially
constituted by the brain and peripheral organs such as liver, kidney,
lung and gut. Actually, the Vmax values
found for tyramine oxidation in rat adipose tissue (around 12 nmol
tyramine oxidized/min/mg protein) are close to those previously
reported for rat liver membranes (Carpéné et
al., 1995a
). In fact, a substantial capacity to oxidize bioamines
was already documented a decade ago in brown and white adipocytes in
which the presence of SSAO, an oxidase mainly characterized by its
resistance to classical MAO inhibitors and its complete inhibition by
semicarbazide, was described by both the groups of Callingham and
Buffoni (Barrand and Callingham, 1982
, 1984
; Raimondi et
al., 1991
, 1992
). However, both the high level of oxidative
deamination and the diversity of the enzymes involved in this activity
brought us to question the functional relevance of amine oxidases,
especially in the white adipose tissue which has never been considered
in studies of the peripheral effects of MAO inhibitors.
First, the high level of MAO activity observed in rat white adipocytes
could be suspected from the high density of
I2-sites found in the adipose tissues of various
animal species, including man (Langin, 1990
) since these sites are now
believed to be located on the MAOs on the basis of the following
observations (reviewed in Parini et al., 1996
).
Second, maximal tyramine oxidation in adipocyte crude membranes was
comparable to that observed in intact cells when calculated on a per
milligram membrane protein basis. Moreover,
Km values were close in membranes and in
intact cells. These findings suggest that internalization of tyramine
in adipocytes is not a limiting step for its degradation by the
mitochondrial MAO. Nevertheless, this was not the case for all the
amines because serotonin, a good MAO-A substrate, was apparently less
oxidized in intact fat cells than in membranes. Tyramine is known to be
catabolized by both MAOs and SSAO, but this is not the case for
serotonin. In our model, the relative proportions of the enzymes
involved in the tyramine oxidation look similar in membranes and in
intact cells. It can be deduced from the experiments with inhibitors that around half of the oxidation is catalyzed by SSAO, mainly located
in the plasma membrane (Barrand and Callingham, 1984
; Morris et
al., 1997
) whereas MAO-A predominates over MAO-B for the other
half of oxidation. Evidence that tyramine can readily be oxidized by
crude fat cell membranes but also by intact fat cells and that both
oxidations can be inhibited by MAO inhibitors or semicarbazide raises
the question of the role of amine oxidation in adipose tissue biology.
In addition to their scavenging action on circulating amines, the amine
oxidases are involved in oxidative stress and apoptosis in various cell
types via their oxidation products that are aldehydes, acids, ammonium
and hydrogen peroxide. However, concerning adipocytes, only one group
has mentioned apoptosis (Prins and O'Rahilly, 1997
) whereas the
insulin mimicking effect of hydrogen peroxide has previously been
frequently described (Heffetz et al., 1992
; May and De
Haën, 1979
; Mukherjee, 1980
; Taylor and Halperin, 1979
). Hydrogen
peroxide can act directly or via the catalysis of vanadate transformation into peroxovanadate (Shisheva and Shechter, 1993
). We
thus tested in our work, whether the hydrogen peroxide generated by the
amine oxidase activity could modulate a biological response highly
sensitive to insulin: glucose uptake. When tested alone, tyramine
barely stimulated glucose transport. The neurotransmitter serotonin and
the adrenergic agonist phenylephrine, which behave as stronger
competitors of tyramine oxidation in membranes than in intact fat
cells, were totally inefficient. We estimated, from the apparent
kinetic constants of oxidation, that 1 mM tyramine can generate up to
approximately 40 µM H2O2
in the incubation medium, at least in our conditions (45-min oxidation
with cells equivalent to 30-40 µg protein) and assuming that the
reaction stoichiometry is one mole of hydrogen peroxide formed per mole of tyramine oxidized (Yu, 1986
), and that no
H2O2 degradation occurred.
In view of this overestimate, it is likely that tyramine oxidation did
not produce sufficient hydrogen peroxide to activate glucose transport
since the addition of exogenous
H2O2 stimulates glucose
transport only at doses higher than 100 µM. An attempt to increase
H2O2 accumulation by
increasing the duration of tyramine oxidation was unsuccessful.
However, incubation of tyramine with vanadate at doses inefficient by
themselves, revealed a powerful synergism on glucose transport that
appeared to be dependent on hydrogen peroxide formation. Serotonin,
phenylephrine and agmatine did not markedly stimulate glucose transport
in the presence of vanadate. Thus, it appears that the capacity of a
given monoamine to stimulate glucose transport depends on its oxidation
by intact fat cells. Whether the lack of effect of serotonin or
phenylephrine on glucose transport was due to low internalization into
the cell, to limited selective oxidation by MAOs, to a lack of
oxidation by SSAO, or to a counterregulatory mechanism mediated by the
stimulation of their respective receptors, remains to be established.
The lack of effect of agmatine fits with the findings of Weitzel
et al. (1980)
who reported that this substance was able to
mimick the antilipolytic effect of insulin but was devoid of any action on glucose metabolism and of hypoglycemic effects.
Evidence for the involvement of
H2O2 in the
tyramine-vanadate synergism was supplied by the inhibitory action of
catalase. Catalase treatment did not affect the basal or
insulin-stimulated glucose transport regardless of the presence of
vanadate, but totally abolished the action of
H2O2 only when added before
vanadate. When H2O2 and
vanadate were mixed to form peroxovanadate before the addition of
catalase, the action of the powerful insulinomimetic compound was
unaffected. The removal by catalase of the remaining H2O2 from the
H2O2-vanadate mixture,
which is generally included in the protocol of peroxovanadate
preparation by various investigators (Fantus et al., 1989
;
Shisheva and Shechter, 1993
), was therefore without any effect on
peroxovanadate-dependent transport. However, when tyramine, vanadate
and catalase were added together with the fat cells for 45 min, there
was a complete inhibition of glucose transport with high doses of the
enzyme. It could be suspected that, in these conditions, hydrogen
peroxide was divided between its interaction with vanadate and its
degradation by catalase. Finally, it can be argued that hydrogen
peroxide formation was exclusively due to the fat cell oxidases because
no tyramine oxidation occurred in the incubation medium alone (see
"Materials and Methods"). This excludes a putative stimulation of
glucose transport by hydrogen peroxide generated from contaminants of
albumin preparations such as spermine oxidase as previously described
(Livingston et al., 1977
). Thus, the large stimulation of
glucose transport obtained with the mixture of vanadate and tyramine
seemed to be due to peroxovanadate. It is noteworthy that tyramine
mixed with an inefficient dose of vanadate induced half of the GLUT4
translocation maximally obtained with insulin. Alternatively, the
reduction of vanadate into vanadyl by fat cells, which has been shown
to be prevented by H2O2,
could also be a mechanism by which tyramine potentiates the effects of
vanadate, since vanadyl, but not vanadate, is able to inhibit several
kinases and even to inhibit the lipogenic effect of insulin (Elberg
et al., 1994
). Whatever the chemical form of vanadium
mediating the synergism observed, the
H2O2 generation induced by
adipocyte amine oxidases appears to be involved in the
tyramine-dependent activation of glucose transport.
To further assess whether the oxidases involved in tyramine oxidation
were also involved in tyramine-induced glucose transport, we compared
inhibitions of the two phenomena. Concerning tyramine oxidation by
intact fat cells, the inhibition curves of the MAO inhibitors were
clearly shifted to the right when compared to the curves obtained with
the membrane preparations. However, semicarbazide equally inhibited
oxidation in disrupted or intact cells, with half-maximal inhibitions
occurring in the 75 to 125 µM range. The potency of semicarbazide in
inhibiting the tyramine-dependent glucose transport was also of the
same order of magnitude: half-maximal inhibition was attained with 100 µM of the carbonyl reagent. These observations indicate that SSAO was
readily inhibited by semicarbazide in intact cells, an observation in
agreement with the studies of Barrand (Barrand and Callingham, 1984
)
and the recent localization of SSAO mainly in plasma membranes but also
in microsomal membranes of rat adipocytes (Morris et al.,
1997
; Enrique Tarancon et al., 1998
). However, it is
important to note that, although it inhibits only half the tyramine
oxidation by fat cells, semicarbazide totally blocked
tyramine-dependent glucose transport (see figs. 1 and 5). This means
either that 1) only the
H2O2 generated by SSAO was
involved in the recruitment of glucose transporters or 2) lowering
endogenous H2O2 production
under a given threshold was sufficient to avoid subsequent vanadate
oxidation and activation of glucose transport. Detracting from the
first hypothesis is the fact that tyramine-dependent glucose transport
was also inhibited by the MAO inhibitors clorgyline, phenelzine and
pargyline, thus also implicating the involvement of MAO in the observed
transport activity. In addition, the relative blocking properties of
clorgyline (MAO-A inhibitor) and selegiline (MAO-B inhibitor) were the
same for tyramine oxidation and tyramine-dependent glucose transport. These results suggest that MAO-A was more involved than MAO-B in both
phenomena. In support of the second "threshold" hypothesis, it
should be mentioned that, in the presence of 0.1 mM vanadate, exogenous
hydrogen peroxide did not stimulate glucose uptake when added at 10 µM but activated it by up to 62 ± 16% of the maximal insulin
effect when tested at 50 µM (n = 3). Moreover, the
difference in the maximal inhibitions induced by clorgyline between
oxidation (partial inhibition) and transport (complete inhibition)
suggests, as was the case with semicarbazide, the existence of a
threshold hydrogen peroxide level necessary to oxidize vanadium and
activate glucose uptake. Otherwise, a loss of selectivity of the
inhibitors tested at 1 mM could be evoked to eliminate both hypotheses,
but this would be contradictory with: 1) the additivity of pargyline and semicarbazide for the inhibition of tyramine oxidation in disrupted
and intact cells and 2) the low efficiency of selegiline which was the
weaker inhibitor for both oxidation and hexose transport. Although it
is difficult to determine on the relative importance of SSAO and MAO in
the tyramine-induced glucose transport from our results, we have
already mentioned that, in rat cardiomyocytes, the serotonin
stimulation of glucose transport was reduced by the MAO inhibitors
clorgyline and tranylcypromine but unaffected by semicarbazide (Fischer
et al., 1995
). To summarize, some amines can stimulate
glucose uptake via both MAO-A and SSAO in adipocytes and via
essentially MAO-A in cardiomyocytes.
Whether the relative importance of MAO-A, MAO-B and SSAO in
amine-dependent glucose transport depends on their relative expression in a given cell type remains to be elucidated. Another complexity in
the investigation of the respective roles of the different amine
oxidases is that most of the substrates are poorly selective and only
few amines are exclusively degraded by one type of oxidase. Moreover,
this substrate selectivity is species-dependent (for review, see Lyles,
1995
) and gives more complexity to the definition of the relative
involvement of each amine oxidase in cellular H2O2 production.
Our results show that tyramine is readily oxidized by adipocytes and strongly potentiates the effects of vanadium on glucose transport through the generation of hydrogen peroxide. Both vanadium and hydrogen peroxide are well known for their insulin-mimicking properties but also for their toxic side-effects. Simultaneously administering amines and vanadate to the adipocytes induces a large insulin-like effect via the amine oxidase-generated H2O2. So, MAO and SSAO could then act to increase the therapeutic benefits of vanadate rather than being mere scavengers of circulating amines. Indeed, an individual being treated with vanadate as an insulin substitute could be given tyramine to generate peroxovanadate in the target cells thus enhancing the antidiabetic effects.
| |
Acknowledgments |
|---|
The authors thank Emi Fontana and Gilles Hickson for their help, Peter Winterton for editing the English manuscript and Marc Jousseaume for the care of animals.
| |
Footnotes |
|---|
Accepted for publication December 4, 1997.
Received for publication September 8, 1997.
1 This work was supported in part by Accords INSERM/CSIC. L.M. is the recipient of a grant from I.R.I.Servier.
Send reprint requests to: Dr. Carpéné Christian, INSERM U317, BAT L3 ILB, Chr Rangueil 31403 Toulouse, Cedex, France.
| |
Abbreviations |
|---|
MAO, monoamine oxidase; SSAO, semicarbazide-sensitive amine oxidase; 2-DG, 2-deoxyglucose; PM, plasma membranes; LDM, low density microsomes; SDS PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; KRBH, Krebs Ringer bicarbonate hepes.
| |
References |
|---|
|
|
|---|
2-adrenergic antilipolytic effect of UK14304 in rat adipocytes.
Biochem Pharmacol
40:
437-445[Medline].
-adrenergic agonist phenylephrine.
Am J Physiol
270:
C1211-C1220
2-adrenergic binding sites.
Mol Pharmacol
37:
876-885[Abstract].This article has been cited by other articles:
![]() |
S. Garcia-Vicente, F. Yraola, L. Marti, E. Gonzalez-Munoz, M. J. Garcia-Barrado, C. Canto, A. Abella, S. Bour, R. Artuch, C. Sierra, et al. Oral Insulin-Mimetic Compounds That Act Independently of Insulin Diabetes, February 1, 2007; 56(2): 486 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Iglesias-Osma, M. J. Garcia-Barrado, V. Visentin, M. F. Pastor-Mansilla, S. Bour, D. Prevot, P. Valet, J. Moratinos, and C. Carpene Benzylamine Exhibits Insulin-Like Effects on Glucose Disposal, Glucose Transport, and Fat Cell Lipolysis in Rabbits and Diabetic Mice J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1020 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vega, P. Chacon, J. Monteseirin, R. El Bekay, M. Alvarez, G. Alba, J. Conde, J. Martin-Nieto, F. J. Bedoya, E. Pintado, et al. A new role for monoamine oxidases in the modulation of macrophage-inducible nitric oxide synthase gene expression J. Leukoc. Biol., June 1, 2004; 75(6): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tardif, N. Julien, J.-L. Chiasson, and L. Coderre Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1055 - E1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abella, L. Marti, M. Camps, M. Claret, J. Fernandez-Alvarez, R. Gomis, A. Guma, N. Viguerie, C. Carpene, M. Palacin, et al. Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Activity Exerts an Antidiabetic Action in Goto-Kakizaki Rats Diabetes, April 1, 2003; 52(4): 1004 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mercier, M. Moldes, K. E. Hadri, and B. Feve Regulation of Semicarbazide-Sensitive Amine Oxidase Expression by Tumor Necrosis Factor-alpha in Adipocytes: Functional Consequences on Glucose Transport J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1197 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morin, V. Visentin, D. Calise, L. Marti, A. Zorzano, X. Testar, P. Valet, Y. Fischer, and C. Carpene Tyramine Stimulates Glucose Uptake in Insulin-Sensitive Tissues in Vitro and in Vivo via Its Oxidation by Amine Oxidases J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1238 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. El Hadri, M. Moldes, N. Mercier, M. Andreani, J. Pairault, and B. Feve Semicarbazide-Sensitive Amine Oxidase in Vascular Smooth Muscle Cells: Differentiation-Dependent Expression and Role in Glucose Uptake Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 89 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Visentin, N. Morin, E. Fontana, D. Prevot, J. Boucher, I. Castan, P. Valet, D. Grujic, and C. Carpene Dual Action of Octopamine on Glucose Transport into Adipocytes: Inhibition via beta 3-Adrenoceptor Activation and Stimulation via Oxidation by Amine Oxidases J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 96 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Marti, A. Abella, C. Carpene, M. Palacin, X. Testar, and A. Zorzano Combined Treatment With Benzylamine and Low Dosages of Vanadate Enhances Glucose Tolerance and Reduces Hyperglycemia in Streptozotocin-Induced Diabetic Rats Diabetes, September 1, 2001; 50(9): 2061 - 2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morin, J.-M. Lizcano, E. Fontana, L. Marti, F. Smih, P. Rouet, D. Prévot, A. Zorzano, M. Unzeta, and C. Carpéné Semicarbazide-Sensitive Amine Oxidase Substrates Stimulate Glucose Transport and Inhibit Lipolysis in Human Adipocytes J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 563 - 572. [Abstract] [Full Text] |
||||
![]() |
N. Andrés, J. M. Lizcano, M. J. Rodríguez, M. Romera, M. Unzeta, and N. Mahy Tissue Activity and Cellular Localization of Human Semicarbazide-sensitive Amine Oxidase J. Histochem. Cytochem., February 1, 2001; 49(2): 209 - 218. [Abstract] [Full Text] |
||||
| |||||||